| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0000900 | Exon-Exon | chr10:31609507-31750166 | chr10:31320578-31461237 | 322 nt | 0.4627 |
| hsa_ZEB1_0001000 | Exon-Exon | chr10:31609507-31799803 | chr10:31320578-31510875 | 1883 nt | 0.4498 |
| hsa_ZEB1_0001100 | Exon-Exon | chr10:31609507-31803636 | chr10:31320578-31514708 | 1989 nt | 0.4465 |
| hsa_ZEB1_0001400 | Intron-Exon-Intron | chr10:31613448-31676195 | chr10:31324519-31387266 | 250 nt | 0.3440 |
| hsa_ZEB1_0001500 | Intron-Intron | chr10:31613456-31614014 | chr10:31324527-31325085 | 559 nt | 0.2970 |
| hsa_ZEB1_0001600 | Intron-Intron | chr10:31614847-31615594 | chr10:31325918-31326665 | 748 nt | 0.3409 |
| hsa_ZEB1_0001700 | Intron-Intron | chr10:31616623-31617009 | chr10:31327694-31328080 | 387 nt | 0.3230 |
| hsa_ZEB1_0001800 | Intron-Intron | chr10:31622492-31623121 | chr10:31333563-31334192 | 630 nt | 0.3016 |
| hsa_ZEB1_0001900 | Intron-Intron | chr10:31622527-31622916 | chr10:31333598-31333987 | 390 nt | 0.3103 |
| hsa_ZEB1_0002000 | Intron-Exon-Intron | chr10:31623525-31644803 | chr10:31334596-31355874 | 250 nt | 0.2720 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].